Labcorp Holdings Inc.
Labcorp Holdings Inc.
Your view on LH
Overview
What the company does, where it operates, and who runs it.
About Labcorp Holdings Inc.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Adam H. Schechter
- Headquarters
- 358 South Main Street, Burlington, NC, US
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Adam H. Schechter
- Headquarters
- 358 South Main Street, Burlington, NC, US
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Labcorp Holdings Inc., and the rating behind it. LH last traded at $311.54, 25.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Labcorp Holdings Inc.. Starting points for Labcorp Holdings Inc.: P/E 25.6, EPS $12.27, beta 0.85 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Labcorp Holdings Inc.. Labcorp Holdings Inc. paid $2.88 per share over the last year — a 0.9% yield at the current $311.54 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Labcorp Holdings Inc.. Trailing twelve-month EPS for Labcorp Holdings Inc. stands at $12.27. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Labcorp Holdings Inc.. Labcorp Holdings Inc. has reported as a listed company since 1990. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Labcorp Holdings Inc. valued side by side against its closest peers. Labcorp Holdings Inc. is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Labcorp Holdings Inc., and how their positions are changing. At a $25.55B market value, institutional positions materially move Labcorp Holdings Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Labcorp Holdings Inc. executives and directors. Shares of Labcorp Holdings Inc. have traded between $209.38 and $293.72 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Labcorp Holdings Inc.. Labcorp Holdings Inc. is a $25.55B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Labcorp Holdings Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Labcorp Holdings Inc.. Coverage tracks Labcorp Holdings Inc. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.